Research programme: selective androgen receptor modulators - Endoceutics

Drug Profile

Research programme: selective androgen receptor modulators - Endoceutics

Alternative Names: EM 8420

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Endoceutics
  • Class
  • Mechanism of Action Selective androgen receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Muscular atrophy; Osteoporosis

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Muscle-wasting in Canada
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoporosis in Canada
  • 09 May 2007 Preclinical trials in Muscle wasting in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top